Stay updated on GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Sign up to get notified when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.

Latest updates to the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the GEN-009 cancer vaccine study, including its design, eligibility criteria, locations, outcomes, and sponsor information, instead of a 403 error page.SummaryDifference66%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA notice about NIH’s terminology transition appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedA 403 Forbidden error page is now displayed when attempting to view the study record, replacing the study details with a minimal error screen and a Home link.SummaryDifference20%

- Check60 days agoChange DetectedThe page’s revision number was updated from v3.6.6 to v3.7.0. This indicates a backend/template update rather than substantive changes to the study details.SummaryDifference0.0%

Stay in the know with updates to GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.